SCIENTURE HOLDINGS, INC. Warrants and Rights Outstanding
SCIENTURE HOLDINGS, INC. (SCNX) had Warrants and Rights Outstanding of $0 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-08-13
- 2026-06-30: Warrants and Rights Outstanding $0.00.
- 2026-03-31: Warrants and Rights Outstanding $0.00.
- 2025-12-31: Warrants and Rights Outstanding $10.91K.
- 2025-09-30: Warrants and Rights Outstanding $138.62K.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 |
| 2025-12-31 | $10.91K 10-Q · filed 2026-05-15 |
| 2025-09-30 | $138.62K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $197.83K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $273.95K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $919.93K 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.13M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $1.63M 10-Q · filed 2024-08-09 |
| 2023-12-31 | $736.95K 10-K · filed 2025-03-26 |
| 2023-03-31 | $2.69M 10-Q · filed 2023-05-15 |
| 2022-09-30 | $26.92K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $26.92K 10-Q · filed 2022-07-25 |
| 2022-03-31 | $29.95K 10-Q · filed 2022-05-09 |
| 2021-09-30 | $47.10K 10-Q · filed 2021-10-25 |
| 2021-06-30 | $75.88K 10-Q · filed 2021-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |